UK withdraws GMP certificate to Wockhardt

Image
BS Reporter Mumbai
Last Updated : Nov 17 2013 | 4:18 PM IST
Wockhardt Ltd has told BSE the company has received a communication from the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA), informing it of withdrawing the previously issued good manufacturing practice (GMP) certificate to the company's manufacturing facility situated at L1, MIDC, Chikalthana, Aurangabad. It will issue a restricted GMP certificate to the site along with a statement of non-compliance.

In order to avoid market shortage of medically essential products, the GMP certificate will be conditioned to permit continued manufacturing and QC testing of "critical" products in situations where it has been agreed by the national competent authority or EMA that there is no feasible alternative in the market concerned. The scope of the statement of non-compliance is, therefore, limited to medicinal products considered non-critical to public health.

Accordingly, the company would be able to manufacture and supply from the said facility certain medicinal products critical to public health. The impact of the same on the existing business will only be known once the company receives further communication from UKMHRA. The said facility contributes approximately £12 million from the UK and European Union markets to the consolidated annual revenues of the company.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 14 2013 | 12:34 AM IST

Next Story